Tim Streets Post Tim Street Report this post GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokinetics GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokinetics 2 Comments Like Comment Alex Haggett 1y Report this comment This is very interesting, Tim, can't wait to read the follow-up and see how well that works with AID
Supports the liver in the removal of waste products and toxins Helps the immune system function better in chronic complaints Protects cells from damage caused by disease, medication or old age Relevant for liver stress, chronic illness and recovery after anesthesia Liposomal form reaches the cells where regular glutathione does not When do you see results
Similar content being viewed by others Introduction Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver diseases ranging from simple steatosis (accumulation of triglyceride (TG) inside hepatocytes) to non-alcoholic steatohepatitis (NASH), which is defined as the presence of hepatic steatosis and inflammation along with hepatocyte death
Im stunned
Compared to diets high in processed foods, dietary patterns that emphasize whole foods: Are more nutritious Are more filling Promote weight loss Are easier to stick with Reduce the risk of chronic diseases such as heart disease and diabetes Processed foods are designed to encourage overeating, so its important to get them out of the house and focus on stocking lots of whole foods like: Whole fruits and vegetables Whole grains such as rolled oats, brown rice, quinoa, whole-grain pasta, etc
This detoxification process is particularly important in todays environment, where exposure to pollutants and chemicals is common